rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Adam Wagner

Officer

Company insider

Files Form 4 as: SVP, Head of Cronos Israel, Cronos Group.

In numbers

Trades disclosed
33
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
1
Companies where not an officer
0
First trade
10 May 2024
Last trade
12 May 2026
Last filed
14 May 2026

Companies traded

Where they are an officer
CRON Cronos GroupOfficer · Pharmaceuticals · last 12 May 20260 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
12 May 2026filed 14 May 2026CRON Cronos GroupPharmaceuticalsSEC FORM 4 Code M—10,367 at $0.00filing
12 May 2026filed 14 May 2026CRON Cronos Groupoption or derivative · PharmaceuticalsSEC FORM 4 Code M—10,367 at $0.00filing
12 May 2026filed 14 May 2026CRON Cronos Groupoption or derivative · PharmaceuticalsSEC FORM 4 Code M—10,367 at $0.00filing
12 May 2026filed 14 May 2026CRON Cronos GroupPharmaceuticalsSEC FORM 4 Code M—10,367 at $0.00filing
10 May 2026filed 12 May 2026CRON Cronos GroupPharmaceuticalsSEC FORM 4 Code M—10,063 at $0.00filing
10 May 2026filed 12 May 2026CRON Cronos GroupPharmaceuticalsSEC FORM 4 Code M—10,407 at $0.00filing
10 May 2026filed 12 May 2026CRON Cronos Groupoption or derivative · PharmaceuticalsSEC FORM 4 Code M—10,063 at $0.00filing
10 May 2026filed 12 May 2026CRON Cronos Groupoption or derivative · PharmaceuticalsSEC FORM 4 Code M—10,063 at $0.00filing
10 May 2026filed 12 May 2026CRON Cronos Groupoption or derivative · PharmaceuticalsSEC FORM 4 Code M—10,407 at $0.00filing
10 May 2026filed 12 May 2026CRON Cronos Groupoption or derivative · PharmaceuticalsSEC FORM 4 Code M—10,407 at $0.00filing
10 May 2026filed 12 May 2026CRON Cronos GroupPharmaceuticalsSEC FORM 4 Code M—10,063 at $0.00filing
10 May 2026filed 12 May 2026CRON Cronos GroupPharmaceuticalsSEC FORM 4 Code M—10,407 at $0.00filing
12 Mar 2026filed 16 Mar 2026CRON Cronos GroupPharmaceuticalsSEC FORM 4 Code M—15,715 at $0.00filing
12 Mar 2026filed 16 Mar 2026CRON Cronos Groupoption or derivative · PharmaceuticalsSEC FORM 4 Code M—15,715 at $0.00filing
12 Mar 2026filed 16 Mar 2026CRON Cronos Groupoption or derivative · PharmaceuticalsSEC FORM 4 Code M—15,715 at $0.00filing
12 Mar 2026filed 16 Mar 2026CRON Cronos GroupPharmaceuticalsSEC FORM 4 Code M—15,715 at $0.00filing
9 Mar 2026filed 10 Mar 2026CRON Cronos Groupoption or derivative · PharmaceuticalsSEC FORM 4 Code A—63,189 at $0.00filing
9 Mar 2026filed 10 Mar 2026CRON Cronos Groupoption or derivative · PharmaceuticalsSEC FORM 4 Code A—63,189 at $0.00filing
7 Nov 2025filed 10 Nov 2025CRON Cronos Groupoption or derivative · PharmaceuticalsSEC FORM 4 Code A—60,728 at $0.00filing
12 May 2025filed 13 May 2025CRON Cronos Groupoption or derivative · PharmaceuticalsSEC FORM 4 Code A—31,102 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Christopher MartensGeneral Manager · General Manager at Cronos Group, filing Form 4 there in the last year
Jason Marc AdlerDirector · Director at Cronos Group, filing Form 4 there in the last year
James Daniel RudykDirector · Director at Cronos Group, filing Form 4 there in the last year
Murray R. GarnickDirector · Director at Cronos Group, filing Form 4 there in the last year
Terrence Gregory Joseph DoucetOfficer · Officer at Cronos Group, filing Form 4 there in the last year